Dynamic Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Dynamic Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-249,231	Closed	-$3.1M	–	468
2016 Q4	$3.1M	Buy	+249,231	New	+$3M	0.33%	95
2016 Q3	–	Sell	-188,768	Closed	-$1.4M	–	499
2016 Q2	$1.4M	Buy	+188,768	New	+$1.42M	0.16%	222
2015 Q4	–	Sell	-583,841	Closed	-$3.41M	–	494
2015 Q3	$3.41M	Buy	+583,841	New	+$4.5M	0.93%	4
2015 Q1	–	Sell	-15,905	Closed	-$109K	–	393
2014 Q4	$109K	Buy	+15,905	New	+$99.5K	0.06%	263
2014 Q3	–	Sell	-26,800	Closed	-$171K	–	500
2014 Q2	$171K	Buy	26,800 +7,500	+39%	+$51.6K	0.05%	381
2014 Q1	$156K	Buy	+19,300	New	+$150K	0.05%	380

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Dynamic Capital Management's ARIA Position: Q1 2017 in Review

Dynamic Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 249,231 shares — an estimated $3.1M sold.

Dynamic Capital Management first reported a position in ARIA in Q1 2014 and held it in 6 quarters. The position peaked at $3.41M in Q3 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Dynamic Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Dynamic Capital Management sold 249,231 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $3.1M.
Dynamic Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 6 quarters.
Dynamic Capital Management's Ariad Pharmaceuticals Inc position peaked at $3.41M in Q3 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Dynamic Capital Management's 13F filing for Q1 2017, filed 15 May 2017.